Pressmeddelande

Arctic Bioscience – Mandatory notification of trade

Cision Publicerad: 22 Apr 2022 20:52

Vartdal Holding AS, a legal person closely associated with a person discharging managerial responsibilities in Arctic Bioscience, has today bought 12,531 shares in Arctic Bioscience at an average price of NOK 16 per share. Following the transaction, Vartdal Holding AS holds 1,040,286 shares in Arctic Bioscience.

Vartdal Holding AS is owned 33,33 % by Future Invest AS, which again is owned 100 % by Jan Endre Vartdal, member of the Board of Directors in Arctic Bioscience.

In total, all legal persons closely associated with Jan Endre Vartdal, holds 1,843,887 shares in Arctic Bioscience after today’s transaction.

Please refer to the attached notification of trading for further details.

This information is subject to the disclosure requirements pursuant to Regulation EU 596/2014 (MAR) article 19 number 3 and the Norwegian Securities Trading Act § 5-12.

Bifogade filer

20220422 Appendix 3 Notifying Transactions Vartal Holding AShttps://mb.cision.com/Main/20422/3551420/1567838.pdf

Nyheter om Arctic Bioscience

Läses av andra just nu

Innehåller annonslänkar. Investeringar innebär risk (se här)

Tips: 50% rabatt hos fondroboten Opti

Dags att komma igång med sparande? Fondroboten Opti erbjuder en populär spartjänst som är perfekt för regelbundet månadssparande. Just nu får nya kunder som använder Börskollens unika kampanjkod BORSKOLLEN50 automatiskt 50 % rabatt på Optis avgift i 3 månader!